Home
Discussion
Documents
Contact
Membership
Username:
Password:
Remember me
Create new account
I forgot my password
UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development
UNAIDS strongly applauds today's announcement by the Bill & Melinda Gates Foundation to invest USD 10 billion into research and development of vaccines over the next 10 years. The announcement, made at the World Economic Forum in Davos, is a welcome step forward in commitment to vaccine research, however large gaps in funding for the research and development of vaccines still remain...
31 January 2010
Immune Memory Formation Seen In Early Stages Of Viral Infection
In an acute viral infection, most of the white blood cells known as T cells differentiate into cells that fight the virus and die off in the process. But a few of these "effector" T cells survive and become memory T cells, ensuring that the immune system can respond faster and stronger the next time around...
30 January 2010
Higher viral load during early pregnancy, poor adherence, associated with increased risk of HIV infection for infants
A higher viral load during the earlier stages of pregnancy is an important risk factor for mother-to-child transmission of HIV, even when a woman’s viral load is below 500 copies/ml at the time of delivery, French investigators report in the February 15
th
edition of
Clinical Infectious Diseases
.
09 February 2010
HIV treatment responses in everyday care matching clinical trial levels
Patients receiving routine HIV care through a large US hospital had treatment responses that matched responses rates seen in recent clinical trials, indicating that very high rates of undetectable viral load are achievable in everyday clinical care, US investigators report in the February 15
th
edition of
Clinical Infectious Diseases
.
09 February 2010
Less resistance with FTC than 3TC when combined with tenofovir
Amongst patients experiencing a rebound in viral load, those taking 3TC (lamivudine,
Epivir
) in combination with tenofovir (
Viread
) were more likely than those taking FTC (emtricitabine,
Emtriva
) and tenofovir to develop a number of key resistance mutations.
08 February 2010
Welcome to
www.shivag.co.uk
, the website of the Scottish HIV and AIDS Group. Membership of SHIVAG is open to members of all professional groups and voluntary bodies working in support of persons infected or affected by HIV in Scotland.
Search the site:
Match All
Match Any
Registration for the 2010 SHIVAG annual general meeting
on March 12th 2010 at Stirling is now open. Places are limited - so please book early, but only if you are sure you are going to be able to attend.
Discussion Forum
Do you want to get a message out to the whole SHIVAG membership?
Post your message in the discussion forum and it will be emailed to all members.
Members can choose to opt out of these mailings - just uncheck the box in the left hand column on any of the discussion pages or edit your mailing list details (top right!).
Document Archive
Got something to share?
This is the place where you'll find links and documents like clinical protocols, guidelines, position papers, committee minutes etc - you can comment or upload documents of your own.
What's new in the forum...
14/01/2010
SHIVAG AGM 2010
20/01/2010
NHS QIS HIV team flyer
24/12/2008
Scottish HIV Action Plan
What's new in the archive...
08/02/2010
SHIVAG 2010 Meeting Agenda
21/01/2010
Reloaded QIS flyer
01/12/2009
Scottish Government HIV Action Plan
More documents...
Edit your mailing list details
The SHIVAG
mailing list
is now maintained online. Once you've registered you can edit your own details to make sure you hear about meetings, new guideline documents and so on.
Access to many areas of the website is restricted to members - if you work in the field of HIV care in Scotland and you haven't registered, follow the link in the top right corner of the screen to create your login name. There's more information about membership of SHIVAG on the
Membership information page.
From time to time members will receive email newsletters - you can also see
previous newsletters.
You can opt out of receiving email newsletters by editing your mailing list details.